Atlas Trials

Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma

3 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma

RecordFirmDate
Study of T-DXd Monotherapy in Patients With HER2-expressing Locally Advanced or Metastatic Gastric or GEJ Adenocarcinoma Who Have Received 2 or More Prior Regimens (NCT04989816)AstraZeneca2021-08-20
A Study of Trastuzumab in Combination With Capecitabine and Cisplatin in Patients With Tissue HER2- But Serum HER2+ AGC (NCT04309578)Asan Medical Center2020-03-12
Apatinib With Pembrolizumab in Previously Treated Advanced Malignancies (NCT03407976)University of Utah2018-06-19

Track Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma automatically

Every clearance here is in the API, with alerts when new ones post.